Interaction with alcohol is unknown. Please consult your doctor.

Bharglob 16.5% Injection may be unsafe to use during pregnancy.Animal studies have shown adverse effects on the foetus, however, there are limited human studies. The benefits from use in pregnant women may be acceptable despite the risk. Please consult your doctor.

Bharglob 16.5% Injection should be used with caution during lactation. Breast feeding should be held until the treatment of the mother is completed and the drug is eliminated from her body.

Do not drive unless you are feeling well.You may experience side effects (for example dizziness or nausea) during treatment with the Bharglob 16.5% Injection that might affect the ability to drive.

Bharglob 16.5% Injection should be used with caution in patients with kidney disease. Dose adjustment of Bharglob 16.5% Injection may be needed. Please consult your doctor.

Bharglob 16.5% Injection is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of Bharglob 16.5% Injection may not be needed in these patients. Please consult your doctor.